Skip to main content
Article
Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility.
British Journal of Haematology (2002)
  • Marco Mielcarek, Fred Hutchinson Cancer Research Center
  • J. Maciej Zaucha, Fred Hutchinson Cancer Research Center
  • Brenda Sandmaier, Fred Hutchinson Cancer Research Center
  • David Maloney, Fred Hutchinson Cancer Research Center
  • James Butrynski, Fred Hutchinson Cancer Research Center
  • Michael Maris, Fred Hutchinson Cancer Research Center
  • Lyle Feinstein, Fred Hutchinson Cancer Research Center
  • Beverly Torok‐Storb, Fred Hutchinson Cancer Research Center
  • Rainer Storb, Fred Hutchinson Cancer Research Center
Publication Date
January 2, 2002
DOI
10.1046/j.1365-2141.2002.03268.x
Citation Information
Marco Mielcarek, J. Maciej Zaucha, Brenda Sandmaier, David Maloney, et al.. "Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility." British Journal of Haematology Vol. 116 Iss. 2 (2002) p. 500 - 501
Available at: http://works.bepress.com/lyle-feinstein/7/